SCHEMBL982372

SCHEMBL982372

O=C(Cc1ccc2nsnc2c1)N1CCC(c2cc(Cl)ccc2Cl)=N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 1/20 0.50
ORAI1 Q96D31 2/20 0.40
KDM4E B2RXH2 5/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
SAE1 Q9UBE0 1/20 0.38
UBA2 Q9UBT2 1/20 0.38
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
MCHR1 Q99705 1/20 0.35
ECE2 P0DPD6 1/20 0.34
GAA P10253 1/20 0.34
RORC P51449 1/20 0.34
THRB P10828 2/20 0.33
PPARG P37231 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL981003 0.91 MET (0.42) METORAI1KDM4EMAPTALDH1A1
SCHEMBL981648 0.88 MET (0.42) METKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL980254 0.86 PGR (0.46) METKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL979452 0.84 PGR (0.41) METORAI1KDM4EMAPTALDH1A1
SCHEMBL981257 0.82 MET (0.47) METORAI1MAPTALDH1A1SMN1; SMN2
SCHEMBL979929 0.81 ECE2 (0.36) METKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL981799 0.81 MET (0.48) METORAI1SMN1; SMN2LMNAKMT2A
SCHEMBL982252 0.80 ALDH1A1 (0.43) METKDM4EMAPTALDH1A1SMN1; SMN2
SCHEMBL984420 0.80 HCRTR1 (0.45) KDM4EMAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL981037 0.80 ECE2 (0.34) METKDM4EMAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1917248-B1 1-ACYLDIHYDROPYRAZOL DERIVATIVES MERCK PATENT GMBH (DE) 2015-08-19 EP claimed
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MERCK PATENT GESELLSCHAFT (DE) 2008-10-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249095-A1 1-Acyldihydropyrazole Derivatives MET, FLT3, ERBB3 MET 1/4885ORAI1 4824/4885KDM4E 1005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.